[{"Assets_0_Q3_USD":48187000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":911700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":910800000.0,"StockholdersEquityConverted_0_Q3_USD":7954100000.0,"StockholdersEquity_0_Q3_USD":7757000000.0,"RevenuesConverted_3_Q3_USD":20318500000.0,"RevenuesConverted_1_Q3_USD":6772800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":906700000.0,"NetIncomeLossConverted_3_Q3_USD":3855600000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":5104200000.0,"EarningsPerShareDiluted_3_Q3_USD":4.23,"EarningsPerShareDiluted_1_Q3_USD":1.22,"EarningsPerShareBasic_3_Q3_USD":4.25,"EarningsPerShareBasic_1_Q3_USD":1.22,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.7,"NetIncomeLossConverted_1_Q3_USD":1110100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":907700000.0,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20211027"}]